Sanofi Healthcare to infuse Euro 400 million in Hyderabad GCC by 2030

Written by Ruchika Sharma Published On 2024-07-18T15:33:03+05:30 | Updated On 18 July 2024 3:33 PM IST

Dupixent approved in EU for young children with eosinophilic esophagitis

Hyderabad: Sanofi Healthcare India Pvt Ltd has announced a substantial expansion of its Global Capacity Centre (GCC) here outlining plans to inject Euro 400 million into the facility over the next six years, out of which Euro 100 million will be pumped in by next year.

At a press conference held, Madeleine Roach, Executive Vice President of Business Operations at Sanofi, highlighted the strategic significance of this expansion. She revealed that over the next two years, the GCC will expand to host up to approximately 2,600 employees, solidifying its position as the largest among Sanofi's four global hubs.

"We make quite a significant commitment. This is obviously a long term strategy. To set our deep footprint here, we are going to make a commitment of 400 million until 2030 (about Rs 3600 crore)," she said, adding that the centre currently has 1,000 employees. The official further said that the investments will primarily go into acquisition of talent and building new capabilities in order to run an operation of this scale, besides the state of the art facilities in Hyderabad. Established in 2019, the Hyderabad hub has grown exponentially from being a medical hub to now providing several best-in-class services for Sanofi's global functions and affiliates across the world, she said.

Emmanuel Frenehard, Executive Vice President and Chief Digital Officer, Sanofi said the ambition is to be the first biopharma company powered by Artificial Intelligence (AI) at scale. "From discovery to treatment, we are using AI ethically and safely to get to market faster with our drugs as there's plenty of unmet needs. We intend to onboard talent at the Hyderabad hub to embrace the power of AI across our value chain to harness the pace of scientific discovery, improve our productivity and place better decision intelligence in the hands of our people," he said.

A senior official of the Pharma giant said 50 per cent of the Hyderabad centre's staff hold PhDs and Masters in Pharmaceutical Sciences, about 10 per cent are freshers from colleges such as National Institute of Pharmaceutical Education And Research (NIPER), and 20 per cent are tech people from IITs and other institutes.

Telangana Minister for Industries D Sridhar Babu inaugurated the facility at HiTECH City here alongside Arunish Chawla, Secretary, Department of Pharmaceuticals and Thierry Berthelot, Consul General of France in Bangalore, a press release from Sanofi said

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751